原发性卵巢癌肉瘤1例报告并文献复习(4)
[19]BERTON-RIGAUD D， DEVOUASSOUX-SHISHEBORAN M， LEDERMANN J A， et al. Gynecologic cancer intergroup (GCIG) consensus review for uterine and ovarian carcinosarcoma[J]. International Journal of Gynecological Cancer， 2014，24(9 Suppl 3)： S55-S60.
[20]EVANS T， MATULONIS U. PARP inhibitors in ovarian cancer：evidence， experience and clinical potential[J]. Therapeutic Advances in Medical Oncology， 2017，9(4)：253-267.
[21]KAMEL D， GRAY C， WALIA J S， et al. PARP Inhibitor drugs in the treatment of breast， ovarian， prostate and panc-reatic cancers： an update of clinical trials[J]. Current DrugTargets， 2018，19(1)：21-37.
[22]ANG Y L E， TAN D S P. Development of PARP inhibitors in gynecological malignancies[J]. Current Problems in Cancer， 2017，41(4)：273-286.
[23]UREYEN I， KARALOK A， CIRIK D A， et al. Uterine and ovarian carcinosarcomas： do they behave similarly[J]？ Journal of Obstetrics and Gynaecology Canada， 2017，39(7)：559-563.
[24]KIM H J， LEE H M， KIM M K， et al. Prognostic assessment of sarcomatous histologic subtypes of ovarian carcinosarcoma[J]. Obstetrics & Gynecology Science， 2017，60(4)：350-356.
[25]SOOD A K， SOROSKY J I， GELDER M S， et al. Primary ovarian sarcoma[J]. Cancer， 2015，1(1469)：431-436.
(本文編辑 黄建乡), 百拇医药(栗佳琦 张华玲 刘翔宇 韩冰 曾满芹 崔竹梅)
[20]EVANS T， MATULONIS U. PARP inhibitors in ovarian cancer：evidence， experience and clinical potential[J]. Therapeutic Advances in Medical Oncology， 2017，9(4)：253-267.
[21]KAMEL D， GRAY C， WALIA J S， et al. PARP Inhibitor drugs in the treatment of breast， ovarian， prostate and panc-reatic cancers： an update of clinical trials[J]. Current DrugTargets， 2018，19(1)：21-37.
[22]ANG Y L E， TAN D S P. Development of PARP inhibitors in gynecological malignancies[J]. Current Problems in Cancer， 2017，41(4)：273-286.
[23]UREYEN I， KARALOK A， CIRIK D A， et al. Uterine and ovarian carcinosarcomas： do they behave similarly[J]？ Journal of Obstetrics and Gynaecology Canada， 2017，39(7)：559-563.
[24]KIM H J， LEE H M， KIM M K， et al. Prognostic assessment of sarcomatous histologic subtypes of ovarian carcinosarcoma[J]. Obstetrics & Gynecology Science， 2017，60(4)：350-356.
[25]SOOD A K， SOROSKY J I， GELDER M S， et al. Primary ovarian sarcoma[J]. Cancer， 2015，1(1469)：431-436.
(本文編辑 黄建乡), 百拇医药(栗佳琦 张华玲 刘翔宇 韩冰 曾满芹 崔竹梅)